| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jan―10 |
Selection and Characterization of SARS-CoV-2 Spike Binding Clickmers |
Nima Moradzadeh, Anna Jonczyk, Anton Schmitz, Volkmar Fieberg, Laia Civit, Julián Valero, Michael Famulok, Günter Mayer |
| 2 |
[GO] |
2025―Nov―29 |
Integrative In Silico and In Vitro Screening of Low Molecular Weight Compounds Targeting SARS-CoV-2 RNA Elements |
Sabrina Toews, Betül Ceylan, Anna Wacker, Megan Ken, Harald Schwalbe |
| 3 |
[GO] |
2025―Nov―02 |
Structure-Based Rational Design of a Selective Hydrolase Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus-2 Nsp3 Macrodomain |
Robin Krishnathas, Konstantin S. Mineev, Nikolaos K. Fourkiotis, Franck Touret, Christos Sideras-Bisdekis, Aikaterini C. Tsika, Santosh Lakshmi Gande, Verena Linhard, Sridhar Sreeramulu, Frank Lennartz, Manfred S. Weiss, Bruno Coutard, Georgios A. Spyroulias, Harald Schwalbe |
| 4 |
[GO] |
2025―Jun―30 |
Chemically Synthesized LRAD3-D1 Interacts with N-terminal Domain of SARS-CoV-2 Spike Protein |
Mrinmoy Jana, Rathina Delipan, Arighna Sarkar, Sreejith R Raran-Kurussi, Rajesh P Ringe, Kalyaneswar Mandal |
| 5 |
[GO] |
2025―Feb―21 |
Biomimetic Recognition of SARS-CoV-2 Receptor-Binding Domain N-Glycans by an Antiviral Synthetic Receptor. |
Carlo Santambrogio, Mirco Toccafondi, Lorena Donnici, Elisa Pesce, Raffaele De Francesco, Renata Grifantini, Erika Ponzini, Francesco Milanesi, Marco Fragai, Cristina Nativi, Stefano Roelens, Rita Grandori, Oscar Francesconi |
| 6 |
[GO] |
2024―Dez―23 |
Cover Feature: Targeting SARS-CoV-2 Proteins: In Silico Investigation with Polypyridyl-Based Zn(II)-Curcumin Complexes (ChemBioChem 24/2024) |
Vedant Gawande, Rajesh Kushwaha, Arif Ali Mandal, Samya Banerjee |
| 7 |
[GO] |
2024―Okt―31 |
Distinct Effects of SARS-CoV-2 Protein Segments on Structural Stability, Amyloidogenic Potential, and α-Synuclein Aggregation |
Vince St. Dollente Mesias, Jianing Zhang, Hongni Zhu, Xin Dai, Jixi Li, Jinqing Huang |
| 8 |
[GO] |
2024―Okt―17 |
Design and evaluation of peptide inhibitors targeting the dimerization of SARS-CoV-2 main protease |
Lu Liu, Yi Yang, Zhiyi Zhao, Xiaoying Li, Yian Chen, Shao-Lin Zhang, Aimin Yang |
| 9 |
[GO] |
2024―Sep―12 |
Targeting SARS-CoV-2 proteins: In Silico Investigation with Polypyridyl-based Zn(II)-Curcumin Complexes |
Vedant Gawande, Rajesh Kushwaha, Arif Ali Mandal, Samya Banerjee |
| 10 |
[GO] |
2024―Jun―15 |
Super-resolution imaging reveals the mechanism of endosomal acidification inhibitors against SARS-CoV-2 infection |
Chunyu Yan, Wei Zhou, Yan Zhang, Xuelian Zhou, Qinglong Qiao, Lu Miao, Zhaochao Xu |
| 11 |
[GO] |
2024―Mai―09 |
Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX-MS |
Ning Song, Wen Zheng, Bin Song, Jie Zheng |
| 12 |
[GO] |
2024―Mai―06 |
Amplification- and Enzyme-Free Magnetic Diagnostics Circuit for Whole-Genome Detection of SARS-CoV-2 RNA |
Enja Laureen Rösch, Rebecca Sack, Mohammad Suman Chowdhury, Florian Wolgast, Margarete Zaborski, Frank Ludwig, Meinhard Schilling, Thilo Viereck, Ulfert Rand, Aidin Lak |
| 13 |
[GO] |
2024―Apr―13 |
SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78 |
Nicholas Johnson, Craig Pattinson, Kate Burgoyne, Karolin Hijazi, Wael E Houssen, Bruce Forbes Milne |
| 14 |
[GO] |
2023―Aug―14 |
Conventional understanding of SARS-CoV-2 Mpro and common strategies for developing its inhibitors |
Kun Zhou, Daquan Chen |
| 15 |
[GO] |
2023―Jun―21 |
Reflections on Navigating a Pandemic: Perspectives from the Chemical Biology Community |
Anne C. Conibear, Nina Hartrampf |
| 16 |
[GO] |
2023―Apr―18 |
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors |
Patrick Moon, Charlotte Zammit, Qian Shao, Lydia Boike, Dustin Dovala, Nathaniel J Henning, Mark Knapp, Jessica N Spradlin, Carl C Ward, Helene Wolleb, Daniel Fuller, Gabrielle Blake, Jason P Murphy, Feng Wang, Yipin Lu, Stephanie A Moquin, Laura Tandeske, Matthew J Hesse, Jeffrey M McKenna, John A Tallarico, Markus Schirle, F. Dean Toste, Daniel K Nomura |
| 17 |
[GO] |
2023―Apr―06 |
Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies |
Camilla Eriksson, Sunithi Gunasekera, Taj Muhammad, Mingshu Zhang, Ida Laurén, Sara M Mangsbo, Martin Lord, Ulf Göransson |
| 18 |
[GO] |
2023―Feb―08 |
Effects of Epitranscriptomic RNA Modifications on the Catalytic Activity of SARS-CoV-2 Replication Complex |
Alexander Apostle, Yipeng Yin, Komal Chillar, Adikari M. D. N. Eriyagama, Reed Arneson, Emma Burke, Shiyue Fang, Yinan Yuan |
| 19 |
[GO] |
2022―Nov―24 |
Pineapple Lectin AcmJRL binds SARS-CoV-2 Spike Protein in a carbohydrate-dependent fashion |
Joscha Meiers, Jan Dastbaz, Sebastian Adam, Sari Rasheed, Susanne H. Kirsch, Peter Meiser, Peter Gross, Rolf Müller, Alexander Titz |
| 20 |
[GO] |
2022―Okt―20 |
Identification of Potential Antiviral Disaccharide Leading Compounds against SARS-CoV-2 through A Computer Aided Study |
Binjie Li, Tianji Zhang, Jin-ping Li, Ming-jia Yu |
| 21 |
[GO] |
2022―Aug―22 |
SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition |
Sven Ullrich, Christoph Nitsche |
| 22 |
[GO] |
2022―Aug―16 |
NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies |
Angus J. Robertson, Jinfa Ying, Ad Bax |
| 23 |
[GO] |
2022―Jul―06 |
Corrigendum: Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2 |
Jovan Dragelj, Maria Andrea Mroginski, Kourosh H. Ebrahimi |
| 24 |
[GO] |
2022―Jul―04 |
Synthetic α-Helical Peptides as Potential Inhibitors of the ACE2 SARS-CoV-2 Interaction |
Pascal M. Engelhardt, Sebastián Florez Rueda, Marco Drexelius, Jörg-Martin Neudörfl, Daniel Lauster, Christian P. R. Hackenberger, Ronald Kühne, Ines Neundorf, Hans-Günther Schmalz |
| 25 |
[GO] |
2022―Jun―02 |
Luminescent Assay for the Screening of SARS-CoV-2 MPro Inhibitors |
Daan Sondag, Jona Merx, Emiel Rossing, Thomas J. Boltje, Dennis W. P. M. Löwik, Frank H. T. Nelissen, Mark van Geffen, Cornelis van ’t Veer, Waander L. van Heerde, Floris P. J. T. Rutjes |
| 26 |
[GO] |
2022―Mai―31 |
Why Omicron Variant of SARS-CoV-2 is Less Fatal? |
Lipeng Liao, Jiaming Zhang, Yuchuan Wang, Qiuyun Liu |
| 27 |
[GO] |
2022―Apr―01 |
Omicron: Understanding the latest variant of SARS-CoV-2 and strategies for tackling the infection |
SREEKANTH REDDY OBIREDDY, Ujwala Guntakanti, Anitha Kowthalam, Subha Marata Chinna Subbarao, Wing-Fu Lai |
| 28 |
[GO] |
2021―Nov―05 |
The Role of Spike Protein Mutations in the Infectious Power of SARS-COV-2 Variants: A Molecular Interaction Perspective |
Santiago A. Gómez, Natalia Rojas-Valencia, Sara Gómez, Chiara Cappelli, Albeiro Restrepo |
| 29 |
[GO] |
2021―Sep―20 |
On the weak binding and spectroscopic signature of SARS-CoV-2 nsp14 interaction with RNA |
Ayaz Hassan, Graziela C Sedenho, Phelipe A. M. Vitale, Mona N Oliveira, Frank Nelson Crespilho |
| 30 |
[GO] |
2021―Sep―16 |
The role of spike protein mutations in the infectious power of SARS-COV-2 variants: A molecular interaction perspective |
Santiago A Gomez, Natalia Rojas-Valencia, Sara Gomez, Chiara Cappelli, Albeiro Restrepo |
| 31 |
[GO] |
2021―Jul―15 |
Hidden in plain sight: Natural products of commensal microbiota as an environmental selection pressure for the rise of new variants of SARS-CoV-2 |
Jovan Draglj, Maria Andrea Mroginski, Kourosh Honarmand Ebrahimi |
| 32 |
[GO] |
2021―Jun―23 |
Preliminary Structural Data Revealed that the SARS-CoV-2 B.1.617 Variant’s RBD binds to ACE2 receptor stronger than the Wild Type to Enhance the Infectivity |
Abbas Khan, Dong-Qing Wei, Kafila Kousar, Jehad Abubaker, Sajjad Ahmad, Javaid Ali, Fahd Al-Mulla, Syed Shujait Ali, N. Nizam-Uddin, Abrar Mohammad Sayaf, Anwar Mohammad |
| 33 |
[GO] |
2021―Jun―16 |
α
V
β
6
Integrin: An Intriguing Target for COVID-19 and Related Diseases |
Kelly Bugatti |
| 34 |
[GO] |
2021―Mai―18 |
Metal Complexes as Antiviral Agents for SARS-CoV-2 |
Johannes Karges, Seth M. Cohen |
| 35 |
[GO] |
2020―Dez―22 |
Ferritin as a Platform for Creating Antiviral Mosaic Nanocages: Prospects for Treating COVID-19 |
Kourosh Honarmand Ebrahimi |
| 36 |
[GO] |
2020―Nov―13 |
Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2 |
Merel A. T. Plassche, Marta Barniol-Xicota, Steven H. L. Verhelst |
| 37 |
[GO] |
2020―Nov―11 |
Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex |
Brian McNaughton, Pedro A. Rosario |
| 38 |
[GO] |
2020―Okt―29 |
Optical Biosensors for Virus Detection: Prospects for COVID-19 |
Hemanth Maddali, Catherine E Miles, Joachim Kohn, Deirdre Marie O'Carroll |
| 39 |
[GO] |
2020―Okt―21 |
Why does the novel Coronavirus Spike Protein interact so strongly with the human ACE2? A thermodynamic answer. |
Jones de Andrade, Paulo Fernando Bruno Gonçalves, Paulo Augusto Netz |
| 40 |
[GO] |
2020―Okt―08 |
Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options |
SREEKANTH REDDY OBIREDDY, Lai Wing-Fu |
| 41 |
[GO] |
2020―Sep―28 |
Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution |
Santiago A. Gomez, Natalia Rojas-Valencia, Sara Gomez, Franco Egidi, Chiara Cappelli, Albeiro Restrepo |
| 42 |
[GO] |
2020―Sep―22 |
Chemical Translational Biology-Guided Molecular Diagnostics: The Front Line To Mediate the Current SARS-CoV-2 Pandemic |
Yifan Dai |
| 43 |
[GO] |
2020―Jul―27 |
Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2 |
Merel A. T. van de Plassche, Marta Barniol-Xicota, Steven Verhelst |
| 44 |
[GO] |
2020―Mai―05 |
Trends and innovations in biosensors for COVID-19 mass testing |
Ibon Santiago |
| 45 |
[GO] |
2020―Feb―05 |
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV |
Wenshe Liu, Jared S. Morse, Tyler Lalonde, Shiqing Xu |
